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Effect of PAG1 on Src-Family Kinase Trafficking in Neuroblastoma Exosomes
Background
SRC-family	kinases	(SFKs)	are	important	in	regulating	cell-fate	in	
neuroblastoma	cells.	PAG1	binds	SFKs	and	helps	regulate	their	
activity	by	directing	their	movement	within	the	cell.	To	better	
understand	the	role	of	PAG1,	we	created	a	line	of	mutant	SH-
SY5Y	cells,	called		PAG1TM- cells,	which	express	a	truncated	PAG1	
protein	that	lacks	the	transmembrane	domain.	These	cells	still	
express	high	levels	of	mutant,	cytosolic	PAG1.	We	have	found	
that	PAG1TM- cells	exhibit	a	hyper-cancerous	phenotype	and	have	
higher	global	levels	of	active	phosphorylated	SFKs	(pSFKs).	The	
role	of	pSFKs in	PAG1TM- cells	is	still	unclear.	Protease	protection	
experiments	suggest	that	PAG1TM- cells	may	accumulate	more	
pSFKs in	multivesicular	bodies	(MVBs),	however	fractionation	
experiments	have	indicated	that	pSFKs primarily	localize	to	early	
endosome	and	cytosol	fractions.
Question:	Is	PAG1	important	for	trafficking	of	SFKs	into	exosomes?
Exosomes:
Exosomes	are	small	extracellular	vesicles	(50-100nm	in	
diameter)	that	are	released	by	fusion	of	MVBs	with	the	
plasma	membrane.	Neuroblastoma	cells,	including	SH-SY5Y	
cells,	have	been	shown	to	release	exosomes	containing	SFKs,	
including	FYN	and	LYN.	To	determine	if	PAG1	is	important	for	
trafficking	of	SFKs	into	exosomes,	I	isolated	exosomes	from	
both	wild-type	(WT)	and	PAG1TM- SH-SY5Y	cells	to	compare	
levels	of	SFKs.
SFKs	in	exosomes	of	SH-SY5Y	cells
Methods
Proliferation	assays:
Five	MTT	assays	were	carried	out	with	cells	grown	for	either	2	or	3	days	
in	different	concentrations	of	PP2	(an	SFK	inhibitor).	Growth	rate	indices	
(GRIs)	were	calculated	for	each	assay	individually	with	the	formula	
𝐺𝑅𝐼 = 2&'/& − 1 ,	where	R’ and	R represent	the	number	of	doublings	
per	day	for	experiment	and	control	conditions	respectively.
Exosome	Isolation	by	ultracentrifugation:
Conditioned	media	was	collected	from	cells	after	incubation	for	24	
hours.	Two	spins	were	done	to	remove	cells,	and	larger	cell	fragments:	
one	at	2,000	x	g	for	20	minutes,	and	a	second	at	5,000	x	g	for	60	
minutes.	Exosomes	were	pelleted	from	the	supernatant	by	spinning	at	
40,000rpm	for	90	minutes,	then	dissolved	in	Urea	buffer	containing	
SDS.	Digested	exosomes	were	analyzed	by	Western	blotting.
Cloning	and	sequencing	of	LAN6	cells:
LAN6	cells	were	previously	transfected	with	CRISPR	plasmids	targeting	
exon	5	of	the	PAG1	gene.	Transfected	cells	were	then	cloned	by	limiting	
dilution.	The	targeted	region	of	exon	5	was	amplified	using	PCR	prior	to	
sequencing.
Results
• PAG1TM- cells	proliferate	faster	than	
WT	cells.	
• Proliferation	in	PAG1TM- cells	is	less	
sensitive	to	SFK	inhibition	by	PP2	
than	proliferation	in	WT	cells.	
• PAG1TM- mutation	caused	
decreased	levels	of	total	pSFKs and	
LYN	incorporated	into	exosomes,	
but	had	minimal	effect	on	FYN	in	
SH-SY5Y	cells.
Conclusions
• PAG1TM- mutation	increases	
proliferation	in	SH-SY5Y	cells.
• Increased	proliferation	in	PAG1TM-
cells	is	not	affected	by	
concentrations	of	SFK	inhibitors	
that	inhibit	proliferation	in	WT	
cells.
• Membrane-bound	PAG1	is	required	
for	incorporation	of	pSFKs and	LYN	
into	exosomes.
Questions for future directions
• Are	SFKs	effectively	inhibited	by	PP2	in	
PAG1TM- cells?
• Are	increased	levels	of	pSFKs important	
for	proliferation	in	PAG1TM- cells?
• Does	PAG1TM- bind	SFKs	in	the	cytosol	and	
interfere	with	targeting	of	SFKs?
• Does	PAG1TM- prevent	pSFKs from	
reaching	MVBs,	resulting	in	diminished	
release	of	pSFKs in	exosomes?
• Alternatively,	are	pSFKS in	MVBs	recycled	
back	to	the	cytosol	or	degraded	in	
lysosomes?
• Is	PAG1	exported	into	exosomes	along	
with	SFKs	in	WT	cells?	
• Is	PAG1	required	to	escort	SFKs	into	
exosomes?
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SFK	signaling	in	neuroblastoma:
Increased	growth	rate	in	PAG1TM- cells	and	decreased	
sensitivity	to	PP2. PP2	was	used	at	three	different	
concentrations	to	inhibit	SFKs.	Growth	rates	were	calculated	as	
the	number	of	doublings	per	day	and	compared	by	calculating	
the	growth	rate	index	(GRI),	a	normalized	ratio	(see	methods	for	
formula).	Boxplots	show	the	interquartile	range	of	GRIs	
comparing	PAG1TM- cells	to	WT	cells	(a)	or	of	PP2-treated	to	
control	cells	(b)	for	each	concentration	of	PP2.	*P<0.05,	
**P<0.005,	***P<0.0005.	Student’s	t	test	was	also	calculated	
for	pooled	growth	rates	of	WT	vs.	PAG1TM- cells.	All	P-values	
were	less	than	0.05.		
Proliferation	of	PAG1TM- cells
PAG1TM- LAN6	mutants:	.	LAN6	cells,	another	neuroblastoma	cell-line,	have	a	slower	growing	and	less	differentiated	phenotype	compared	to	SH-
SY5Y	cells.	The	same	PAG1TM- mutation	was	attempted	in	LAN6	cells.	Several	clones	were	isolated	and	sequenced.	Clones	14	and	32	were	identified	
as	heterozygous	mutants,	with		mutations	in	both	copies	of	exon	5.	Sequencing	results	for	clone	14	are	shown	above.	Unfortunately,	we	have	been	
unable	to	verify	a	mutant	phenotype	due	to	difficulty	detecting	the	protein.	
Allele 2- Frameshift deletion
Wild-type:
126 GGAAAAGAAGCCGCGACAGCATAGTGGGGACCATGA 161
Clone 14:
126 GGAAAAGAAGCCCCATGA 155
-E--K--K--P--P-stop
Allele 1- T insertion
Wild-type:
126 GGAAAAGAAGCCGCGACAGCATAGTGGGGACCATGAGAACCTGATGAACGTG 177  
--E--K--K--P--R--Q--H--S--G--D--H--E--N--L--M--N--V-
Clone 14:
126 GGAAAAGAAGCCGCGACAGCATAAGTGGGGACCATGA 170
--E--K--K--P--R--Q--H--K--W--G--P-stop
LAN6	WT LAN6	PAG1	TM-
LAN6	PAG1	TM-
LAN6	PAG1TM- cells
Western	blot	results	of	exosomes: Exosomes	were	isolated	from	WT	and	PAG1TM- cells	and	probed	for	FYN,	
LYN,	pSFK and	the	exosomal marker	CD9	(also	known	as	Tetraspanin-29)	in	a	Western	blot.	To	determine	the	
relative	amount	of	SFKs	expressed	in	exosomes,	the	SFK	signal	was	divided	by	the	CD9	signal	for	each	
sample.	The	SFK	to	CD9	ratio	is	shown	as	a	percentage	of	the	maximum	between		WT	and	PAG1TM- exosomes	
(a).	Images	of	the	experiment	are	shown	in	(b).
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